semaglutide may 22 injections will no longer be sold at compounding pharmacies after NIH locates semaglutide's brain handle:

Cell 80 , 485500.e7 (2020)

I dont think weve ever seen anything like this. A cheaper alternative Compounding pharmacies are allowed to make a medication thats essentially a copy of a commercially available drug if its active ingredients are listed on the FDAs drug shortage list

That's considerably higher than the price-to-earnings (PE) ratio of the S&P 500 as a whole, which has a trailing P/E of about 32 and a forward P/E of around 20

Iwaza, R., et al

This suggests that MAFG may regulate the ratio of CDCA to CA, thereby controlling bile acid hydrophobicity (by inhibiting CA synthesis without affecting CDCA synthesis), but not the overallbile acid pool size [2, 13]